| dc.contributor.author | Vojtěchová, Zuzana | |
| dc.contributor.author | Milt, Petr | |
| dc.contributor.author | Saláková, Martina | |
| dc.contributor.author | Šmahelová, Jana | |
| dc.contributor.author | Lohynská, Radka | |
| dc.contributor.author | Lacek, Michal | |
| dc.contributor.author | Čoček, Aleš | |
| dc.contributor.author | Krátká, Zuzana | |
| dc.contributor.author | Tachezy, Ruth | |
| dc.date.accessioned | 2024-10-14T09:45:51Z | |
| dc.date.available | 2024-10-14T09:45:51Z | |
| dc.date.issued | 2024 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14178/2662 | |
| dc.description.abstract | The clinical utility of liquid biopsies as diagnostic, predictive and prognostic biomarkers has been shown for several cancers. Our study analyses the dynamics of human papillomavirus (HPV) cell cell-free DNA (cfDNA) levels during the surveillance of patients with oropharyngeal tumours to improve patient management. Here, we present preliminary data on the evaluation of plasma collection methods, and their use in subsequent analyses of the dynamics of HPV cfDNA levels. | en |
| dc.language.iso | en | |
| dc.publisher | Česká společnost chemická | |
| dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
| dc.rights | Creative Commons Attribution 4.0 International | en |
| dc.title | The biomolecular markers for the personalized prediction of the treatment effect in patients with head and neck cancer: Pilot study | en |
| dcterms.accessRights | openAccess | |
| dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
| dc.date.updated | 2024-10-14T09:45:51Z | |
| dc.subject.keyword | HPV cfDNA | en |
| dc.subject.keyword | tumour | en |
| dc.subject.keyword | plasma | en |
| dc.identifier.eissn | 2336-7210 | |
| dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
| dc.date.embargoStartDate | 2024-10-14 | |
| dc.type.obd | 110 | |
| dc.type.version | info:eu-repo/semantics/acceptedVersion | |
| dc.identifier.obd | 653777 | |
| dc.subject.rivPrimary | 30000::30200::30204 | |
| dc.subject.rivSecondary | 10000::10600::10607 | |
| dcterms.isPartOf.name | Czech Chemical Society Symposium Series | |
| dcterms.isPartOf.issn | 2336-7202 | |
| dcterms.isPartOf.journalYear | 2024 | |
| dcterms.isPartOf.journalVolume | 22 | |
| dcterms.isPartOf.journalIssue | 6 | |
| uk.faculty.primaryId | 115 | |
| uk.faculty.primaryName | Přírodovědecká fakulta | cs |
| uk.faculty.primaryName | Faculty of Science | en |
| uk.faculty.secondaryId | 108 | |
| uk.faculty.secondaryName | 1. lékařská fakulta | cs |
| uk.faculty.secondaryName | First Faculty of Medicine | en |
| uk.department.primaryId | 1034 | |
| uk.department.primaryName | Katedra genetiky a mikrobiologie | cs |
| uk.department.primaryName | Department of Genetics and Microbiology | en |
| uk.department.secondaryId | 2133 | |
| uk.department.secondaryName | Onkologická klinika 1. LF UK a FTN | cs |
| uk.department.secondaryName | Department of Oncology | en |
| uk.event.name | The third annual meeting of the National Institute of Virology and Bacteriology (NIVB) | |
| dc.description.pageRange | 253-253 | |
| dc.type.obdHierarchyCs | ABSTRAKT::abstrakt::abstrakt v elektronické podobě | cs |
| dc.type.obdHierarchyEn | ABSTRACT::abstract::abstract in e-form | en |
| dc.type.obdHierarchyCode | 110::130::136 | en |
| uk.displayTitle | The biomolecular markers for the personalized prediction of the treatment effect in patients with head and neck cancer: Pilot study | en |
